Parameter
| Biomarker | BTA | Full name | Bladder Tumor Antigen | Molecular Type | Protein (tumor-associated antigen) |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Diagnosis (high-risk detectio | ||
| Disease | Bladder Cancer (BC) | Disease Subtypes | / | ||
| Organ | Bladder | Test Sample / Technology Platform | Urine (BTA stat & BTA TRAK kits) | ||
| Pathobiological Mechanisms | Detects tumor-associated antigens in urine; strong detection capability for intermediate- to high-risk bladder cancer | ||||
| Clinical Availability Status | Commercial kits widely used for primary screening in intermediate-/high-risk cohorts | ||||
| Notes and Dynamics | Susceptible to false positives due to UTI or urolithiasis; requires confirmatory combined assays | ||||